Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Coumarin derivatives with potential anticancer and antibacterial activity: Design, synthesis, VEGFR‐2 and DNA gyrase inhibition, and in silico studies
Soha H. Emam, Rasha A. Hassan, Eman O. Osman, et al.
Drug Development Research (2023) Vol. 84, Iss. 3, pp. 475-499
Closed Access | Times Cited: 17

Showing 17 citing articles:

Discovery and Mechanistic Studies of Dual-Target Hits for Carbonic Anhydrase IX and VEGFR-2 as Potential Agents for Solid Tumors: X-ray, In Vitro, In Vivo, and In Silico Investigations of Coumarin-Based Thiazoles
Salma M. Hefny, Tarek F. El‐Moselhy, Nabaweya Sharaf El-Din, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 7406-7430
Closed Access | Times Cited: 12
Design and synthesis of novel hexahydrobenzo[4,5]thieno[2,3‐d]pyrimidine derivatives as potential anticancer agents with antiangiogenic activity via VEGFR‐2 inhibition, and down‐regulation of PI3K/AKT/mTOR signaling pathway
Safaa E. Seif, Zeinab Mahmoud, Wagnat W. Wardakhan, et al.
Drug Development Research (2023) Vol. 84, Iss. 5, pp. 839-860
Closed Access | Times Cited: 13
Design, synthesis, anticancer, and antibacterial evaluation of some quinazolinone‐based derivatives as DHFR inhibitors
Eman O. Osman, Soha H. Emam, Amr Sonousi, et al.
Drug Development Research (2023) Vol. 84, Iss. 5, pp. 888-906
Closed Access | Times Cited: 13
Design, synthesis, anticancer evaluation, and in silico studies of some thieno[2,3‐d]pyrimidine derivatives as EGFR inhibitors
Menna Tallah M. Sayed, Peter A. Halim, Afaf K. El‐Ansary, et al.
Drug Development Research (2023) Vol. 84, Iss. 6, pp. 1299-1319
Closed Access | Times Cited: 8
Thiazolation of phenylthiosemicarbazone to access new thiazoles: anticancer activity and molecular docking
Walid E. Elgammal, Safaa S. Shaban, Essam M. Eliwa, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 12, pp. 1219-1237
Closed Access | Times Cited: 2
Novel pyrazolo[3,4-d]pyrimidine derivatives: design, synthesis, anticancer evaluation, VEGFR-2 inhibition, and antiangiogenic activity
Ahmed M. Abdelhamed, Rasha A. Hassan, Hanan H. Kadry, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 12, pp. 2640-2657
Open Access | Times Cited: 6
Eradication of Biofilms on Catheters: Potentials of Tamarix ericoides Rottl. Bark Coating in Preventing Catheter-Associated Urinary Tract Infections (CAUTIs)
Mohammed H. Karrar Alsharif, Muhammad Musthafa Poyil, Salman Bin Dayel, et al.
Life (2024) Vol. 14, Iss. 12, pp. 1593-1593
Open Access | Times Cited: 1
Electrochemical Synthesis of Versatile Pyrimidine and Oxadiazoles Tethered Triazoles as Inhibitors of VEGFR-2 in Human Breast Cancer Cells
Akshay Ravish, Tejaswini P. Siddappa, Xi Zhang, et al.
Catalysts (2023) Vol. 13, Iss. 10, pp. 1353-1353
Open Access | Times Cited: 4
From Sea to Science: Coral Aquaculture for Sustainable Anticancer Drug Development
Hung‐Yu Lin, Tsen‐Ni Tsai, Kai‐Cheng Hsu, et al.
Marine Drugs (2024) Vol. 22, Iss. 7, pp. 323-323
Open Access | Times Cited: 1
New S‐substituted‐3‐phenyltetrahydrobenzo[4,5]thieno[2,3‐d]pyrimidin‐4(3H)‐one scaffold with promising anticancer activity profile through the regulation and inhibition of mutated B‐RAF signaling pathway
Safaa E. Seif, Wagnat W. Wardakhan, Rasha A. Hassan, et al.
Drug Development Research (2024) Vol. 85, Iss. 7
Open Access | Times Cited: 1
Modulation of Transcription Profile Induced by Antiproliferative Thiosemicarbazone Metal Complexes in U937 Cancer Cells
Serena Montalbano, Franco Bisceglie, Giorgio Pelosi, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1325-1325
Open Access | Times Cited: 3
Synthesis, characterization and crystal structure of methyl 2-(2-oxo-2H-chromen-4-ylamino)benzoate
Henrique V. P. Hollauer, Rachel C. V. Novas, Guilherme P. Guedes, et al.
Acta Crystallographica Section E Crystallographic Communications (2023) Vol. 79, Iss. 9, pp. 842-846
Open Access | Times Cited: 2
Synthesis, In Vitro α-Amylase Inhibition Activity and Molecular Docking of some Coumarin Derivatives
Emna Chaabouni, Ines Dhouib, Emna Khdhiri, et al.
Chemistry Africa (2024) Vol. 7, Iss. 6, pp. 3109-3118
Closed Access
Design, synthesis, biological evaluation, and docking studies of novel triazolo[4,3-b]pyridazine derivatives as dual c-Met/Pim-1 potential inhibitors with antitumor activity
Mohamed E. Mahmoud, Eman Ahmed, Hamdy M. Ragab, et al.
RSC Advances (2024) Vol. 14, Iss. 41, pp. 30346-30363
Open Access
Synthesis and Anticancer Evaluation of Novel Coumarin Derivatives
Thi Thanh Hai Dam, Doan Phuong Anh Chan, Minh Tan Phan, et al.
ChemistrySelect (2024) Vol. 9, Iss. 37
Closed Access
SYNTHESIS AND EVALUATION OF A COUMARIN SCHIFF-BASE FOR IN VITRO ANTIBACTERIAL ACTIVITY AGAINST STAPHYLOCOCCUS AUREUS
SHREYA SHET, B. V. SUMA
International Journal of Pharmacy and Pharmaceutical Sciences (2024), pp. 26-30
Open Access
Hybrids based on coumarins and their anticancer activities: A bibliometric analysis
Wilson Cardona- Galeano, Howard Ramírez-Malule, David Gómez- Ríos
Journal of Applied Pharmaceutical Science (2023)
Open Access
Page 1

Scroll to top